細胞内シグナル伝達の世界市場予測（～2022年）：内分泌、傍分泌...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22

2 RESEARCH METHODOLOGY 23
2.1 SECONDARY DATA 24
2.1.1 KEY DATA FROM SECONDARY SOURCES 24
2.2 PRIMARY DATA 25
2.2.1 KEY DATA FROM PRIMARY SOURCES 26
2.3 MARKET SIZE ESTIMATION 26
2.3.1 BOTTOM-UP APPROACH 27
2.3.2 TOP-DOWN APPROACH 27
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 29
2.5 ASSUMPTIONS FOR THE STUDY 30

3 EXECUTIVE SUMMARY 31

4 PREMIUM INSIGHTS 36
4.1 CELL SIGNALING: MARKET OVERVIEW 36
4.2 GEOGRAPHIC ANALYSIS: CELL SIGNALING MARKET, BY SIGNALING TYPE &
REGION (2017) 37
4.3 CELL SIGNALING MARKET, BY PATHWAY, 2017–2022 38
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL SIGNALING MARKET 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Rising incidence of chronic diseases 41
5.2.1.2 Availability of funding for cell-based research 42
5.2.1.3 Technological advancements in cell-based research instruments 43
5.2.1.4 Growth of end-use industries 43
 
5.2.2 RESTRAINTS 44
5.2.2.1 High cost of cell signaling systems 44
5.2.2.2 Ethical issues related to embryonic stem cell signaling research 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging markets 45
5.2.3.2 Emergence of microfluidics in cell biology research 45
5.2.4 CHALLENGES 46
5.2.4.1 Complexities related to antibody and reagent development 46

6 GLOBAL CELL SIGNALING MARKET, BY SIGNALING TYPE 47
6.1 INTRODUCTION 48
6.2 ENDOCRINE SIGNALING 49
6.3 PARACRINE SIGNALING 50
6.4 AUTOCRINE SIGNALING 51
6.5 JUXTACRINE SIGNALING 52
6.6 OTHER SIGNALING TYPES 53

7 GLOBAL CELL SIGNALING MARKET, BY PRODUCT 54
7.1 INTRODUCTION 55
7.2 CONSUMABLES 56
7.2.1 ANTIBODIES 57
7.2.2 REAGENTS 58
7.2.3 ASSAY KITS 59
7.2.4 OTHER CONSUMABLES 60
7.3 INSTRUMENTS 60

8 GLOBAL CELL SIGNALING MARKET, BY TECHNOLOGY 63
8.1 INTRODUCTION 64
8.2 MICROSCOPY 65
8.3 FLOW CYTOMETRY 66
8.4 MASS SPECTROMETRY 66
8.5 WESTERN BLOTTING 67
8.6 ELISA 68
8.7 IMMUNOHISTOCHEMISTRY 69
8.8 OTHER TECHNOLOGIES 70

9 GLOBAL CELL SIGNALING MARKET, BY PATHWAY 71
9.1 INTRODUCTION 72
9.2 AKT SIGNALING PATHWAY 73
9.3 AMPK SIGNALING PATHWAY 73
9.4 ERBB/HER SIGNALING PATHWAY 74
9.5 HEDGEHOG SIGNALING PATHWAY 75
9.6 JAK/STAT SIGNALING PATHWAY 76
9.7 NOTCH SIGNALING PATHWAY 76
9.8 NF-ΚB SIGNALING PATHWAY 77
9.9 OTHER SIGNALING PATHWAYS 78

10 CELL SIGNALING MARKET, BY APPLICATION 79
10.1 INTRODUCTION 80
10.2 RESEARCH APPLICATIONS 81
10.2.1 CANCER RESEARCH 82
10.2.2 IMMUNOLOGY RESEARCH 83
10.2.3 STEM CELLS RESEARCH 84
10.2.4 OTHER RESEARCH APPLICATIONS 85
10.3 MEDICAL APPLICATIONS 86

11 GLOBAL CELL SIGNALING MARKET, BY REGION 87
11.1 INTRODUCTION 88
11.2 NORTH AMERICA 89
11.2.1 U.S. 94
11.2.2 CANADA 99
11.3 EUROPE 103
11.3.1 GERMANY 108
11.3.2 FRANCE 112
11.3.3 U.K. 117
11.3.4 ITALY 121
11.3.5 SPAIN 124
11.3.6 REST OF EUROPE (ROE) 128
11.4 ASIA 132
11.4.1 CHINA 137
11.4.2 JAPAN 141
11.4.3 INDIA 146
11.4.4 REST OF ASIA (ROA) 149
11.5 REST OF THE WORLD (ROW) 152

12 COMPETITIVE LANDSCAPE 157
12.1 INTRODUCTION 157
12.2 VENDOR DIVE OVERVIEW 157
12.2.1 VANGUARDS 157
12.2.2 INNOVATORS 157
12.2.3 DYNAMIC PLAYERS 157
12.2.4 EMERGING PLAYERS 157
 
12.3 COMPETITIVE BENCHMARKING 159
12.3.1 PRODUCT OFFERINGS (FOR ALL 25 PLAYERS) 159
12.3.2 BUSINESS STRATEGY (FOR ALL 25 PLAYERS) 160
*Top 25 companies analyzed for this study are – Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon BioSystems, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Cisbio Bioassays (France), Rockland Immunochemicals Inc. (U.S.), BioVision, Inc. (U.S.), Tonbo Biosciences (U.S.), BPS Bioscience, Inc. (U.S.), StressMarq Biosciences Inc. (U.S.), Abeomics, Inc. (U.S.), Sino Biological, Inc. (U.S.), RayBiotech, Inc. (U.S.), MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (Japan), and Santa Cruz Biotechnology, Inc. (U.S.)

13 COMPANY PROFILES 161
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
13.1 MERCK KGAA 161
13.2 THERMO FISHER SCIENTIFIC INC. 167
13.3 BECTON, DICKINSON AND COMPANY 172
13.4 BECKMAN COULTER INC. (A SUBSIDIARY OF DANAHER CORPORATION) 175
13.5 BIO-RAD LABORATORIES, INC. 179
13.6 PERKINELMER, INC 185
13.7 QIAGEN N.V. 188
13.8 CELL SIGNALING TECHNOLOGY, INC. 191
13.9 PROMEGA CORPORATION 195
13.10 BIO-TECHNE CORPORATION 198
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14 KEY INNOVATORS 201
14.1 CISBIO BIOASSAYS 201
14.1.1 INNOVATIONS 201
14.2 MILTENYI BIOTEC 201
14.2.1 INNOVATIONS 201
14.3 CELL BIOLABS, INC. 202
14.3.1 INNOVATIONS 202
 

15 APPENDIX 203
15.1 INDUSTRY INSIGHTS 203
15.2 DISCUSSION GUIDE 204
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 208
15.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 210
15.5 AVAILABLE CUSTOMIZATIONS 211
15.6 RELATED REPORTS 211
15.7 AUTHOR DETAILS 212